Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

References

• World Health Organization. World Malaria Report. Geneva: WHO; 2015 Available from: http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/. Accessed 428, 2018.
   Google Scholar
• Diji-geske R, Olasehinde G, Fadina I, Arogundade D, Darby P. Epidemiological data of falciparum malaria in Ado-Odo/Ota, Southwest Ogun State, Nigeria. Data Brief. 2018;19:1398–1402.30246071
   PubMed Web of Science ®Google Scholar
• Olasehinde GI. In- Vitro and Molecular Studies on the Resistance of P. Falciparum to Antimalarial Drugs in Ogun State, south- western Nigeria. Lambert Academic publishing; 2010 978-3-8433-7825-3Available from: http://eprints.covenantuniversity.edu.ng/24/2/Olasehinde_phdwork_%281%29.pdf.
   Google Scholar
• Olasehinde GI, Ojurongbe DO, Akinjogunla OJ, Egwari LO, Adeyeba AO. Prevalence of malaria and predisposing factors to antimalarial drug resistance in Southwestern Nigeria. Res J Parasitol. 2015;10(3):92–101. doi:10.3923/jp.2015.92.101
   Google Scholar
• Shweta S, Bikash M, Rakesh S. Challenges of drug resistant malaria. Parasite. 2014;21:61. doi:10.1051/parasite/201405925402734
   PubMed Web of Science ®Google Scholar
• Olliaro PL, Taylor WRJ. Antimalarial compounds: from bench to bedside. J Exp Biol. 2003;206:3753–3759.14506210
   PubMed Web of Science ®Google Scholar
• Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin Chem. 2011;57(5):675–687. doi:10.1373/clinchem.2010.15376721383043
   PubMed Web of Science ®Google Scholar
• Zachary D, Mwenge L, Muyoyeta M, et al. Field comparison of OraQuick ADVANCE rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC Infect Dis. 2012;12:183. doi:10.1186/1471-2334-12-18322871032
   PubMed Web of Science ®Google Scholar
• SahebJamee M, Boorghani M, Ghaffari SR, Atarbashi MF, Keyhani A. Human papillomavirus in saliva of patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2009;14:525–528. doi:10.4317/medoral.14.e525
   Web of Science ®Google Scholar
• Ghayour NZ, Oormazdi H, Akhlaghi L, et al. Detection of Plasmodium vivax and Plasmodium falciparum DNA in human saliva and urine: loop-mediated isothermal amplification for malaria diagnosis. Acta Trop. 2014;136:44–49. doi:10.1016/j.actatropica.2014.03.02924721227
   PubMed Web of Science ®Google Scholar
• Putaporntip C, Buppan P, Jongwutiwes S. Improved performance with saliva and urine as alternative DNA sources for malaria diagnosis by mitochondrial DNA-based PCR assays. Clin Microbiol Infect. 2011;17:1484–91.32. doi:10.1111/j.1469-0691.2011.03507.x21595789
   PubMed Web of Science ®Google Scholar
• Kenji OM, Samuel TY, Livo FE, et al. Detection of plasmodium falciparum DNA in saliva samples stored at room temperature: potential for a non-invasive saliva-based diagnostic test for malaria. Malar J. 2017;16:434. doi:10.1186/s12936-017-2084-529078786
   PubMed Web of Science ®Google Scholar
• Fidock DA, Nomura T, Cooper RA, Su X, Talley AK, Wellems TE. Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum. Mol Biochem Parasitol. 2000;110:1–10. doi:10.1016/S0166-6851(00)00249-810989140
   PubMed Web of Science ®Google Scholar
• Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257–263. doi:10.1056/NEJM20010125344040311172152
   PubMed Web of Science ®Google Scholar
• Plowe CV, Roper C, Barnwell JW, et al. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J. 2007;6:121. doi:10.1186/1475-2875-6-12117822535
   PubMed Web of Science ®Google Scholar
• Ojurongbe O, Ogungbamigbe TO, Fagbenro-Beyioku AF, Fendel R, Kremsner PG, Kun JF. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria. Malar J. 2007;6:41. doi:10.1186/1475-2875-6-4117428334
   PubMed Web of Science ®Google Scholar
• Pickard AL, Wongsrichanalai C, Purfield A, et al. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother. 2003;47:2418–2423. doi:10.1128/AAC.47.8.2418-2423.200312878499
   PubMed Web of Science ®Google Scholar
• Basco LK, Ringwald P. Analysis of the key Pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaounde, Cameroon. J Infect Dis. 2001;183:1828–1831. doi:10.1086/32072611372041
   PubMed Web of Science ®Google Scholar
• Dorsey G, Kamya MR, Singh A, Rosenthal PJ. Polymorphisms in the Plasmodium falciparum Pfcrt and Pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis. 2001;183:1417–1420. doi:10.1086/31986511294677
   PubMed Web of Science ®Google Scholar
• Wilson NO, Adjei AA, Anderson W, Baidoo S, Stiles JK. Detection of Plasmodium falciparum histidine-rich protein II in saliva of malaria patients. Am J Trop Med Hyg. 2008;78(5):733–735. doi:10.4269/ajtmh.2008.78.73318458305
   PubMed Web of Science ®Google Scholar
• Oba IT, Spina AM, Saraceni CP, et al. Detection of hepatitis A antibodies by ELISA using saliva as clinical samples. J Inst Trop Med São Paulo. 2000;42:197–200. doi:10.1590/S0036-46652000000400004
   Google Scholar
• Thieme T, Piacentini S, Davidson S, Steingart K. Determination of measles, mumps and rubella immunization status using oral fluid samples. J Am Med Assoc. 1994;272:219–221. doi:10.1001/jama.1994.03520030061029
   Web of Science ®Google Scholar
• Hunt AJ, Connell J, Christofinis G, et al. The testing of saliva samples for HIV-1 antibodies: reliability in a non-clinic setting. Genitourin Med. 1993;69:29–30. doi:10.1136/sti.69.1.298444477
   PubMedGoogle Scholar
• Lima DP, Diniz DG, Moimaz SA, Sumida DH, Okamoto AC. Saliva: reflection of the body. Int J Infect Dis. 2010;14(3):184–188. doi:10.1016/j.ijid.2009.04.022
   PubMed Web of Science ®Google Scholar
• Pooe OJ, Shonhai A, Mharakurwa S. A PCR screen for malaria carrier infections using human saliva samples. Afr J Microbiol Res. 2011;5(28):5120–5126.
   Google Scholar
• Vicki S. Malaria, A Global Challenge. Society for General Microbiology. Available from: https://microbiologyonline.org/file/7416093e224285db89c8ae9761d9f53f.pdf.
   Google Scholar
• World Health Organisation. Status Reports on Artemisinin Resistance and ACT Efficacy. WHO/CDS/GMP/2018.18.
   Google Scholar
• World Health Organisation(2018). World Malaria Report 2018. Geneva. CC BY-NC SA 3.0 IGO. ISBN 978-92-4-156565-3.
   Google Scholar
• Lucie P, Ramadani A, Mercereau-Puijalon O, Augereau J, Benoit-Vical F. Plasmodium falciparum: multifaceted resistance to artemisinins. Malar J. 2016;15:149. doi:10.1186/s12936-016-1206-926955948
   PubMed Web of Science ®Google Scholar
• Conrad MD, Bigira V, Kapisi J, et al. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. Public Lib Sci. 2014;9(8):e105690.
   Google Scholar
• Kaufman E, Lamster IB. The diagnostic application of saliva - a review. Oral Biol Med. 2002;13:197–212.
   Google Scholar
• Taylor SM, Parobek CM, DeConti DK, et al. Absence of putative plasmodium falciparum artemisinin resistance mutations in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211:1680–1688. doi:10.1093/infdis/jiu467
   Web of Science ®Google Scholar
• Edwin PM, Chinweizu EU, Mark IM. Amodiaquine and Ciprofloxaxin combination in plasmodiasis therapy. J Trop Med. 2015;15(1):1–10.
   Google Scholar